Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
9.85 NOK | 0.00% | -1.01% | -6.19% |
Mar. 01 | Arctic Bioscience AS Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Mar. 01 | Transcript : Arctic Bioscience AS, Q4 2023 Earnings Call, Mar 01, 2024 |
Sales 2024 * | 57M 5.2M | Sales 2025 * | 79M 7.2M | Capitalization | 250M 22.78M |
---|---|---|---|---|---|
Net income 2024 * | -30M -2.74M | Net income 2025 * | -50M -4.56M | EV / Sales 2024 * | 1.63 x |
Net cash position 2024 * | 157M 14.32M | Net cash position 2025 * | 106M 9.67M | EV / Sales 2025 * | 1.82 x |
P/E ratio 2024 * |
-8.19
x | P/E ratio 2025 * |
-4.94
x | Employees | 17 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 38.42% |
Latest transcript on Arctic Bioscience
1 week | -5.29% | ||
Current month | -1.30% | ||
1 month | +0.51% | ||
3 months | -4.37% | ||
6 months | +9.93% | ||
Current year | -6.19% |
Managers | Title | Age | Since |
---|---|---|---|
Hogne Hallaråker
FOU | Founder | 58 | 10-12-31 |
Chief Executive Officer | 52 | 22-02-28 | |
Jone R. Slinning
DFI | Director of Finance/CFO | 45 | 22-03-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 44 | 20-12-31 | |
Director/Board Member | 55 | 19-12-31 | |
Harald Nordal
FOU | Founder | 66 | 10-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-25 | 9.85 | 0.00% | 0 |
24-04-24 | 9.85 | 0.00% | 0 |
24-04-23 | 9.85 | -5.29% | 900 |
24-04-22 | 10.4 | +1.96% | 4,265 |
24-04-19 | 10.2 | +2.51% | 1,485 |
Real-time Oslo Bors, April 24, 2024 at 10:45 am EDT
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-6.19% | 22.72M | |
+25.61% | 660B | |
+23.56% | 562B | |
-5.24% | 358B | |
+16.49% | 322B | |
+8.28% | 297B | |
+13.21% | 219B | |
-9.78% | 196B | |
+6.83% | 199B | |
-8.75% | 149B |
- Stock Market
- Equities
- ABS Stock